Buch, Englisch, 420 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 1012 g
Buch, Englisch, 420 Seiten, Format (B × H): 183 mm x 260 mm, Gewicht: 1012 g
Reihe: Cancer Drug Discovery and Development
ISBN: 978-1-58829-028-1
Verlag: Humana Press
Internationally recognized experts in cancer biology and clinical research review the present status of the multimodality approach to the management of solid tumors and speculate on possible future strategies for chemoradiation therapy. The authors detail applications of combined modality therapy in lung, esophageal, breast, gastric, pancreatic, colon, and rectal cancers. They also show how radiation interacts with such chemotherapeutic agents as the platinum complexes, taxanes, and gemcitabine in the treatment of malignant gliomas, and head and neck cancer. A review of how to integrate new specific molecular targeted agents into multimodality therapy in the future.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
Weitere Infos & Material
I. General/Background.- 1 Chemoradiation: Biological Principles and Perspectives.- 2 Fluoropyrimidines as Radiation Sensitizers.- II. Mechanisms of Interaction of Specific Chemotherapeutic Agents with Radiation.- 3 The Role of Platinum Complexes in Combined Modality Therapy.- 4 Taxanes in Combined Modality Therapy.- 5 Camptothecin Radiation Sensitization.- 6 The Role of Gemcitabine in Combined Modality Therapy.- III. Clinical Applications.- 7 Chemoradiation Strategies for Patients with Malignant Gliomas.- 8 Combined Modality Strategies in the Treatment of Head and Neck Cancer.- 9 The Role of Combined Modality Therapy for Stage III Nonsmall-Cell Lung Cancer.- 10 Combined Modality Treatment of Small-Cell Lung Cancer.- 11 The Role of Chemoradiation in the Management of Esophageal Cancer.- 12 Combined Modality Therapy in Locally Advanced Breast Cancer.- 13 Combined Modality Therapy for Gastric, Pancreatic, and Biliary Tract Carcinomas.- 14 Chemoradiation in Therapy for Colon and Rectum Carcinoma.- 15 Chemoradiotherapy in Muscle-Invasive Bladder Cancer.- 16 The Role of Combined Chemotherapy and Radiation Therapy in the Treatment of Gynecologic Malignancies.- IV. Specific Molecular Targeted Agents.- 17 Overview of Specific Molecular Targeted Agents for Combined Modality Therapy.- 18 Receptor Tyrosine Kinases as Therapeutic Targets in Solid Tumors.- 19 Adenoviral p53 Gene Therapy Strategies in Nonsmall-Cell Lung Cancer.- 20 Tumor Microvasculature as a Therapeutic Target During Radiotherapy.- 21 Cancer Drug Discovery and Development: Maximizing the Therapeutic Potential of Matrix Metalloproteinase Inhibitors for the Treatment of Cancer.- 22 The Role of Cyclooxygenase-2 Inhibitors in Combined Modality Therapy.
